Analyst ratings, especially from reputable firms like Needham, can significantly influence investor sentiment and stock prices in the short term. The reiteration of a Buy rating and an ambitious price target suggests a strong vote of confidence in TScan Therapeutics' prospects, likely leading to positive investor sentiment and potential upward movement in the stock's price.